XRP News Today: XRP Holds Above $2.75 as Wellgistics Launches Major XRPL Pharmacy Payment Program

XRP bulls are closely monitoring the $2.75 support level, which analysts argue is critical to maintaining the coin’s upward trajectory. According to market analyst Crypto Joe, a breakdown below $2.75 is considered "highly unlikely" and vital for the continuation of the bullish trend [1]. Currently trading at around $3.14, XRP remains well above this key threshold. The $2.75–$2.90 range has been identified as a decisive zone that could influence the coin’s next move. If XRP were to drop below $3.00–$3.10, analysts warn it could see a pullback toward $2.75, and further to $2.55–$2.62 in the event of continued downward momentum [1]. This support level is also a key Fibonacci level, reinforcing the significance of its defense for the asset’s broader structure [1].

Simultaneously, a major development in XRP’s real-world adoption has emerged with Wellgistics Health confirming the launch of an XRP Ledger-based payment program for U.S. independent pharmacies. The company, which connects over 6,500 pharmacies and 200 manufacturers nationwide, has begun enrolling participants in its newly launched “XRP Implementation Program” [1]. This initiative allows for instant, low-cost on-chain payments and positions Wellgistics as one of the first healthcare firms to deploy XRP at scale. The program is powered by RxERP, Wellgistics’ pharmaceutical ERP platform, and offers benefits such as second-level settlement, 24/7 availability, real-time tracking, and direct transactions without intermediaries [1].

Prominent legal expert and digital asset advocate Bill Morgan has highlighted the development as a major milestone for XRP’s real-world utility. He emphasized that the SEC filing moves beyond pilot rhetoric and into actual implementation, with broader plans to integrate XRP into treasury and capital operations [1]. In Morgan’s view, this signals a shift in how XRP is being used—not just as a speculative asset, but as a functional tool in B2B payments and financial infrastructure.

Looking ahead, Wellgistics has outlined plans to onboard manufacturers and launch Direct-to-Patient (DTP) programs, enabling on-chain transactions and direct medication delivery in coordination with pharmacies and prescribers. If executed as outlined, this could represent one of the most high-profile examples of enterprise-level XRPL adoption in the U.S. healthcare sector, an industry where speed, auditability, and cost efficiency are paramount [1].

The development underscores the growing traction of XRP in enterprise applications, particularly within tightly regulated industries. With additional plans to integrate XRP into treasury and financing operations, the move stands as a strong validation of the asset’s utility beyond speculative markets. As XRP remains above the $2.75 support zone and whale activity suggests sustained bullish sentiment, the combination of on-chain adoption and price resilience highlights a positive outlook for the altcoin’s future.

Source: [1] [XRP Bulls Have to Defend $2.75 as Wellgistics Files Game-Changing XRPL Payment Solution for Pharmacies](https://coinmarketcap.com/community/articles/68a064821a5a623e01742562/)